Freestone Capital Holdings’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-3,628
| Closed | -$247K | – | 461 |
|
|
2024
Q1 | $247K | Hold |
3,628
| – | – | 0.01% | 397 |
|
|
2023
Q4 | $227K | Buy |
+3,628
| New | +$227K | 0.01% | 359 |
|
|
2023
Q3 | – | Sell |
-3,628
| Closed | -$204K | – | 383 |
|
|
2023
Q2 | $204K | Buy |
+3,628
| New | +$204K | 0.01% | 354 |
|
|
2022
Q1 | – | Sell |
-2,972
| Closed | -$225K | – | 589 |
|
|
2021
Q4 | $225K | Buy |
2,972
+164
| +6% | +$12.4K | 0.01% | 453 |
|
|
2021
Q3 | $314K | Sell |
2,808
-46
| -2% | -$5.14K | 0.02% | 341 |
|
|
2021
Q2 | $462K | Buy |
+2,854
| New | +$462K | 0.02% | 281 |
|
|
2021
Q1 | – | Sell |
-439
| Closed | -$67.2K | – | 535 |
|
|
2020
Q4 | $67.2K | Buy |
439
+330
| +303% | +$50.5K | ﹤0.01% | 506 |
|
|
2020
Q3 | $9.12K | Buy |
+109
| New | +$9.12K | ﹤0.01% | 762 |
|